Sponsor or institution
Clinical trials and research at Cabaletta Bio
As of November 12, 2026, Find a Trial lists 5 clinical trials run by Cabaletta Bio that are recruiting, at sites in 6 countries (most in United States (5), Germany (1), Italy (1)). By phase: Phase 1/2 (3), Phase 2/3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 6Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Evaluating CABA-201 for treating generalized myasthenia gravis | Phase 1/2 | Orange, California and 16 other locations | Recruiting | Apr 11, 2024 |
| Evaluating a new CAR T cell therapy for systemic sclerosis | Phase 2/3 | New Haven, Connecticut and 9 other locations | Recruiting | Mar 25, 2024 |
| Evaluating CABA-201 for treating active idiopathic inflammatory myopathy | Phase 2/3 | Orange, California and 37 other locations | Recruiting | Dec 4, 2023 |
| Evaluating CABA-201 for treating active systemic lupus erythematosus | Phase 1/2 | Orange, California and 22 other locations | Recruiting | Nov 7, 2023 |
| Investigating a new cell therapy for pemphigus vulgaris | Phase 1/2 | Redwood City, California and 12 other locations | Recruiting | Jun 9, 2020 |
All recruiting trials (5)
-
Evaluating CABA-201 for treating generalized myasthenia gravis
This study is testing a new cell therapy called CABA-201 to see if it can help adults with generalized myasthenia gravis feel stronger and improve their daily function.
-
Evaluating a new CAR T cell therapy for systemic sclerosis
This study is testing a new CAR T cell therapy to see if it can help people with systemic sclerosis feel better and manage their symptoms.
-
Evaluating CABA-201 for treating active idiopathic inflammatory myopathy
This study is testing a new cell therapy called CABA-201 to see if it can help people with active idiopathic inflammatory myopathy feel better by reducing muscle inflammation and weakness.
-
Evaluating CABA-201 for treating active systemic lupus erythematosus
This study is testing a new cell therapy called CABA-201 to see if it can help people with active lupus and kidney issues feel better and protect their organs.
-
Investigating a new cell therapy for pemphigus vulgaris
This study is testing a new cell therapy for people with pemphigus vulgaris who haven't found relief with standard treatments to see if it can help them feel better.
Quick answers
How many clinical trials run by Cabaletta Bio are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United States (5 trials), Germany (1 trial), Italy (1 trial), United Kingdom (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 3, Phase 2/3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.